— · ai drug discovery · biotech · peptides
One round we have observed, with the investors the report named. Every figure below came from a named source, and where the company reported the raise to the SEC itself, that is shown beside it.
Series B · Apr 2026 · $150M
Decheng Capital lead, CDH VCG lead, Abu Dhabi Investment Authority (ADIA), 5Y Capital, Qiming Venture Partners, GL Ventures, LAV, AstraZeneca, BioTrack Capital, Sinovation Capital, True Light Capital
Reported by Ventureburn
Missing a round, or an investor who was in one? Tell us.